Curing cancer with Cannabidiol?
- CANNABIS OIL, NEWS
- April 24, 2013
In the ever-evolving landscape of health and wellness, Cannabidiol (CBD) has emerged as a buzzword synonymous with natural relief and therapy. A recent article by Health.com delves deep into the essence of CBD, shedding light on its definition, benefits, and potential risks. CBD, a naturally occurring compound found in the Cannabis sativa plant, has garnered
READ MOREIn a landmark clinical trial, researchers have unveiled promising results for treating Tourette syndrome with medicinal cannabis. The study, led by Dr. Philip Mosley of the Wesley Research Institute and QIMR Berghofer Medical Research Institute, in collaboration with the University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics, marks a significant stride in understanding the therapeutic
READ MOREA significant shift from illicit to legal consumption of medicinal cannabis is underway in Australia, reveals a University of Sydney study. As chronicled in the university’s recent article, this transition is marked by a growing preference for prescribed cannabis products over their illicit counterparts. The study highlights that users of prescribed cannabis are more inclined
READ MOREIn a groundbreaking initiative, Australia’s Southern Cross University is spearheading a study to examine the effectiveness of medicinal cannabis in alleviating symptoms of Fibromyalgia Syndrome (FMS). This condition, affecting roughly 2.7% of the global populace, manifests as widespread pain, fatigue, and sleep disturbances, with limited treatment options currently available. The study, supported by Little Green
READ MOREEncouraged by the positive reception of its first medical cannabis product in Australia, Danish company Stenocare is gearing up to introduce another innovative product to the Australian market. Founded in 2017, Stenocare has been a pioneer in the medical cannabis sector, becoming the first Danish company to receive all necessary permits for cultivating, importing, and
READ MOREIn a significant move, New Zealand’s Medsafe has reclassified cannabidiol (CBD), a medicinal cannabis product, from a prescription-only medicine to a restricted medicine available at pharmacies. This change aligns New Zealand with Australia’s approach, which underwent a similar modification in December 2020. While currently, no CBD products are approved in New Zealand, this reclassification opens
READ MORE